At
Atlas Venture
Cambridge MAFounded 200130 employees
Private CapbiotechPrivateOncology
Platform: Biotech VC
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ATL-9462 | ATL-9462 | Phase 2/3 | 1 | CD38 | FLPNH | ||
| Pexasertib | ATL-9971 | Preclinical | 2 | CD38 | NBFSGS | ||
| Daranesiran | ATL-5611 | Phase 2/3 | 1 | CGRP | CholangiocarcinomaMDD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)